A bid waiting to happen

(Full access for Members only)

A bid waiting to happen

25 August 2023

Attentive Undervalued-Shares.com readers have come across this company before: it was briefly referred to as a potential takeover target in a 2022 Weekly Dispatch.

Lo and behold, shortly thereafter, events got into motion, and the company was indeed for sale (if only semi-officially).

However, this was always going to be a drawn-out process. I waited with this in-depth report until matters had settled down, and the news cycle had moved on. The stock is currently going through a period of weakness again, even though it looks like the situation will culminate in a bid before too long now. The current mini sell-off allows investors to pick up stock at an attractive price.

On the same level, one of the key shareholders of this company has recently upped their stake. They now hold a very large position relative to their overall portfolio – speak of a conviction play!

This opportunity is reserved for Undervalued-Shares.com Members, which is why I am not giving away any more details.

Not a Member yet? Sign up for a Membership - just USD 49/year.
Already a Member? Log into your account to download the report.

Most recent

Latest reports (for Members only)

One of the world's best (and cheapest) oil and gas stocks

One of the world's best (and cheapest) oil and gas stocks

The stock of this oil and gas major has started to move, but it remains one of the cheapest large-cap stocks in the world.

Swiss takeover target

A bid waiting to happen

A takeover bid for this Swiss company should come in at least 40% above the current level. Now is the time to pick up stock at an attractive price.

Research Report Dr. Martens

Dr. Martens plc: marching towards turnaround

Successful, timeless brands don't come up for a discounted sale very often. Enter Dr. Martens – a true bargain for contrarian investors.